Insight Charlesbank’s investment in Aptean brings company’s valuation to $2bn TA is set to make 3.5x its equity on the stake sale to Charlesbank, a source told PE Hub. Milana Vinn - January 2 2021 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in